Vodafone Names Aldo Bisio Group Chief Commercial Officer; Vodafone Spain CEO To Step Down

British telecom major Vodafone Group Plc (VOD.L,VOD) announced Thursday the appointment of Aldo Bisio as the Group Chief Commercial Officer, effective January 12, in addition to his current role as CEO of Vodafone Italy.

Bisio has been CEO of Vodafone Italy since January 2014 and is a member of the Group Executive Committee.

Further, the company announced that Vodafone Spain will join the Europe Cluster effective January 12, and report to Europe Cluster CEO, Serpil Timuray.

Colman Deegan, CEO of Vodafone Spain, has decided to step down as CEO, effective March 31. He will support Margherita Della Valle, Vodafone Group's CEO on an interim basis, on strategic initiatives from April 1, until July 31. His successor will be appointed in due course.

Timuray has been CEO of the Europe Cluster since October 2018 and a member of the Group Executive Committee since January 2014.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
United Airlines and Archer Aviation Inc. announced plans to launch the first commercial electric air taxi route in Chicago, between O'Hare International Airport or ORD and Vertiport Chicago. As part of their urban air mobility or UAM network buildout, both companies will utilize Archer's electric vertical takeoff and landing or eVTOL aircraft in the new route. Fort Wayne, Indiana-based Perfection Bakeries D/B/A Aunt Millie's is recalling 8 ct. packages of Our Family White Hot Dog Buns citing the possible presence of undeclared sesame, a known allergen, the U.S. Food and Drug Administration said. The product comes in a printed plastic package marked with "Our Family Hot Dog Buns 8 ct." on the top and has a blue twist tie. Parsippany, New Jersey -based Ascend Laboratories LLC. is recalling Dabigatran Etcxilate capsules citing the detection of N-Nitrosodimethylamine or NDMA impurity, a probable human carcinogen, the U.S. Food and Drug Administration said. The product is used as an oral anticoagulant to lower the risk of stroke and blood clots.
Follow RTT